Cargando...
Promising Response to Thalidomide in Symptomatic β-Thalassemia
Over the past decade, few reports suggested that the drug thalidomide (HbF inducer) may be of value in a subset of transfusion-dependent and non-transfusion dependent thalassemia patients. A cohort of 37 patients with symptomatic β-thalassemia syndrome [14 transfusions dependent thalassemia (TDT), a...
Gardado en:
| Publicado en: | Indian J Hematol Blood Transfus |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer India
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7229055/ https://ncbi.nlm.nih.gov/pubmed/32425386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-019-01231-5 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|